Cartesian Therapeutics, Inc. (RNAC)
NASDAQ·Healthcare·Biotechnology
$7.45
-1.06%
Mkt Cap $299.10M
Analyst Ratings
Buy
5
Hold
0
Sell
0
Price Target (5 analysts)
$25.00
Range $25.00 – $25.00
Implied Upside
+235.6%
Consensus $25.00 vs current $7.45
NASDAQ·Healthcare·Biotechnology
$7.45
-1.06%
Mkt Cap $299.10M
Buy
5
Hold
0
Sell
0
Price Target (5 analysts)
$25.00
Range $25.00 – $25.00
+235.6%
Consensus $25.00 vs current $7.45